Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots

Journal of Clinical Virology

Volumn 53, Issue 2, 2012, Pages 106-109

  Maritz, Jean ^a   Preiser, Wolfgang ^a   Van Zyl, Gert U ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

CAP CTM; Diagnosis; Dried blood spot; HIV; PCR

Indexed keywords

EDETIC ACID; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; FALSE POSITIVE RESULT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; LABORATORY; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA;

BLOOD SPECIMEN COLLECTION; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VIRAL LOAD;

EID: 84855562498     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.12.002     Document Type: Article

References (13)

1. ® TaqMan HIV-1 Qual Test [package insert] 2007, Roche, Branchburg, NJ.
2. Stevens W., Erasmus L., Moloi M., Taleng T., Sarang S. Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants. J Clin Microbiol 2008, 46(December (12)):3941-3945.
3. Uttayamakul S., Likanonsakul S., Sunthornkachit R., Kuntiranont K., Louisirirotchanakul S., Chaovavanich A., et al. Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection. J Virol Methods 2005, 128(September (1-2)):128-134.
4. Leelawiwat W., Young N.L., Chaowanachan T., Ou C.Y., Culnane M., Vanprapa N., et al. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J Virol Methods 2009, 155(February (2)):109-117.
5. Jacob S.M., Anitha D., Vishwanath R., Parameshwari S., Samuel N.M. The use of dried blood spots on filter paper for the diagnosis of HIV-1 in infants born to HIV seropositive women. Indian J Med Microbiol 2008, 26(January-March (1)):71-74.
6. Driver G.A., Patton J.C., Moloi J., Stevens W.S., Sherman G.G. Low risk of contamination with automated and manual excision of dried blood spots for HIV DNA PCR testing in the routine laboratory. J Virol Methods 2007, 146(December (1-2)):397-400.
7. ® product bulletin No. 2007/281 2007, Roche, Branchburg, NJ.
8. Violari A., Cotton M.F., Gibb D.M., Babiker A.G., Steyn J., Madhi S.A., et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359(November (21)):2233-2244.
9. Zanchetta M., Anselmi A., Vendrame D., Rampon O., Giaquinto C., Mazza A., et al. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther 2008, 13(1):47-55.
10. Lima V., Harrigan R., Montaner J.S. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J Acquir Immune Defic Syndr 2009, 51(May (1)):3-6.
11. Mercier B., Burlot L., Férec C. Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay. J Virol Methods 1999, 77(January (1)):1-9.
12. Shearer W.T., Quinn T.C., LaRussa P., Lew J.F., Mofenson L., Almy S., et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997, 336(May (19)):1337-1342.
13. Dickover R.E., Dillon M., Leung K.M., Krogstad P., Plaeger S., Kwok S., et al. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis 1998, 178(August (2)):375-387.